-
1
Adam Davenport appointed CSO in January
-
2
Focus on integrated drug discovery and early decision-making.
-
3
Spatial biology enhances target validation and reduces risk.
-
4
Emphasis on neuroscience amidst high unmet needs.
-
5
Advanced modalities include peptides and antibody-drug conjugates.
-
6
AI and machine learning facilitate data analysis.
-
7
Integrated approach improves capital efficiency and accelerates timelines.
Original Source(s)
Building an Integrated Discovery Engine
An Interview with Adam Davenport, CSO, Concept Life Sciences
February 23, 2026
-
5 min
Related Content
Cirena Launches High-Purity Long RNA to Accelerate CRISPR and Genome-Editing Research
New technology enables faster design cycles and improved editing precision
February 23, 2026
-
2 min
Why Does Ovarian Cancer Spread So Fast?
New research finds that cancer cells partner the body's own protective cells to drive rapid metastasis
February 23, 2026
-
2 min
A Practical Approach to Early-Phase CMC
Integrated, risk-based chemistry, manufacturing and controls strategies support early-phase development, writes Richard Chubb
February 20, 2026
-
7 min
